Skip to content
Home/Companies/Biotech/Enthera
Enthera

Enthera

Biotech·Italy·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Enthera?

Enthera is currently owned by Indaco Venture Partners SGR through Atlante Seed (2011 vintage), since 2020.

Hand-verified · updated 2026-07-23

Indaco Venture Partners SGR
Investor
Indaco Venture Partners SGR
Atlante Seed · 2011 · VC

Key facts

HQItaly
SectorBiotech
StatusActive
Websitewww.entherapharmaceuticals.com

More from Atlante Seed

Other portfolio companies in the same fund.

BiovelocITA
Active
BiotechItaly· 2016
Lumyer
Lumyer
Active
SoftwareItaly· 2016
Sellf
Exited 2018
SaaSItaly· 2016
to
Cocontest
Active
PropTechItaly· 2015
Wish List
Active
TMTItaly· 2015
CellPly
CellPly
Active
MedTechItaly· 2014

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Enthera

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Enthera?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Enthera.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue